Company / R&D Expense
Xenetic Biosciences, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.3M
FY2025
5-year range
$1.7M / $4.8M
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $2M in FY2021 to $44M in FY2017.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -7.6%.
Declined from $5M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +1.3%
- 5-Year CAGR
- -7.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.6%, indicating a declining trend.
- In FY2025, r&d expense decreased 5.9% year-over-year.
- Peak r&d expense was recorded in FY2017.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3M | -5.9% |
| FY2024 | $3.5M | -26.7% |
| FY2023 | $4.8M | +50.8% |
| FY2022 | $3.2M | +82.7% |
| FY2021 | $1.7M | -64.6% |
| FY2020 | $4.9M | +69.5% |
| FY2019 | $2.9M | -29.0% |
| FY2018 | $4.1M | -90.7% |
| FY2017 | $43.7M | +1173.7% |
| FY2016 | $3.4M | +11.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026